Humshaugh & Wark Medical Group

The Practice will be closed on

Wednesday 17^th September 2025 from 1pm

for staff training and will reopen on Thursday 18^th September at 8am.

Find out about conditions, symptoms and treatments, including what to do and when to get help

Find out how your medicine works, how and when to take it, and possible side effects

A pathway is being developed in our ICB area (North East and North Cumbria) for the delivery of weight loss injections. We currently do not have a contract for delivering this at Humshaugh & Wark Medical Group. As soon as we are in a position to offer the treatment we will update this notice.

To be eligible for the NHS injection a patient must have a BMI ≥40 and 4 out of the following 5 conditions.:

• Atherosclerotic Cardiovascular Disease – IHD, CVA/TIA, PAD, HF
• Hypertension – On treatment
• High Cholesterol – On Lipid Lowering Therapy (or LDL >=4.1 or HDL <1.0 for men or HDL <1.3 women or fasting triglycerides >=1.7)
• Obstructive Sleep Apnoea (OSA) – Meets criteria for CPAP or equivalent
• Diabetes Type 2

Phased Primary Care Cohorts (2025–2028)

The programme will develop over the coming years as follows:

• Cohort I (2025-26 ):  4 or more of the comorbidities listed above and BMI ≥40
• Cohort II (2026-27):  4 or more comorbidities listed above and BMI 35-39.9
• Cohort III (2026-2028):  3 or more comorbidities listed above and BMI ≥40